Trial Profile
Post marketing, multicentre study to evaluate efficacy and tolerability of Teriflunomide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Nov 2016
Price :
$35
*
At a glance
- Drugs Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 23 Nov 2016 New trial record